In a nutshell This phase 3 trial aims to determine if androgen suppression along with high dose proton radiation therapy offers more benefit than proton radiation therapy alone. The main outcome investigated is freedom from treatment failure. The details Freedom from treatment failure represents successful treatment with no local cancer...
Read MoreCurrent PSA level-Between 1 to 4 Posts on Medivizor
Recurrence rate after surgical prostate removal in men older than 70 years of age
Due to the increase in life expectancy, there exists an increasing number of patients with prostate cancer (PCA) in many populations. However, there is no consensus on screening and treatment of PCA in the medical fraternity. This paper investigated the oncological outcomes of radical prostatectomy (RP) in older men (> 70) compared to RP outcomes in...
Read MoreEvaluating survival rates in patients with prostate cancer treated with low-dose-rate brachytherapy
In a nutshell The present study evaluated survival rates in patients with prostate cancer (PC) treated with Low-dose-rate prostate brachytherapy (LDR-PB). The main findings were that LDR-PB alone or combined with hormone therapy offers excellent survival in PC patients. Some background Prostate cancer is the most common type of cancer in men....
Read MoreGuidelines for the management of prostate cancer in older men
This paper presents specific guidelines, developed by the International Society of Geriatric Oncology (SIOG), for the treatment of localized and metastatic prostate cancer, specifically in older men. Prostate cancer is predominantly a disease of older men (> 70 years). A systematic review of the literature revealed that besides the...
Read More
